TipRanks
Go Ultimate55% OFF

Newron Pharmaceuticals SpA (NWRN) Balance Sheet

Newron Pharmaceuticals SpA Balance Sheet

Newron Pharmaceuticals SpA's total assets for Q2 2026 were $40.42M, an increase of 0.98% from the previous quarter. CH:NWRN total liabilities were $52.13M for the fiscal quarter, a 1.92% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 40.02M$ 63.91M$ 25.87M$ 37.20M$ 50.49M
$ 51.15M$ 62.45M$ 55.77M$ 51.23M$ 47.38M
$ -11.13M$ 1.46M$ -29.91M$ -14.03M$ 3.11M

Currency in EUR

Newron Pharmaceuticals SpA Debt to Assets

030M60M90M0 %80 %160 %240 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets